| Literature DB >> 23109818 |
Jai-Hong Cheng1, Shau-Yu Lee2, Yi-Yang Lien3, Meng-Shiou Lee4, Shyang-Chwen Sheu2.
Abstract
Polysaccharides play a key role in enhancing immune function and facilitating cellular communication. Here, we purified Nymphaea rubra Roxb. polysaccharides (NR-PS) by treating them with pullulanase. They were then cultured with immature dendritic cells (DCs) derived from rat bone marrow hematopoietic cells (BMHCs). After treatment with bioactive NR-PS with a degree of polymerization (DP) value of 359.8, we found that the DCs underwent morphological changes indicative of activation. CD80/86 (87.16% ± 8.49%) and MHC class II (52.01% ± 10.11%) expression levels were significantly up-regulated by this treatment compared to the controls (65.45% ± 0.97% and 34.87% ± 1.96%). In parallel, endocytosis was also reduced (167.94% ± 60.59%) after treatment with 25 μg/mL of NR-PS as measured by the medium fluorescence intensity compared to the control (261.67% ± 47.26%). Furthermore, the DCs after treatment with 25 μg/mL NR-PS showed increased IL-12 (102.09 ± 10.16 to 258.78 ± 25.26 pg/mL) and IFN-γ (11.76 ± 0.11 to 15.51 ± 1.66 pg/mL) secretion together with reduced IL-10 secretion (30.75 ± 3.35 to 15.37 ± 2.35 pg/mL), which indicates a T(H)1 immune response. In conclusion, NR-PS exhibits stimulatory effects on rat DCs and promotes the secretion of T(H)1 cytokines. Taken together, our studies are the first to show that NR-PS is an immunomodulator affecting the maturation and functioning of DCs.Entities:
Keywords: Nymphaea rubra Roxb.; TH1 immune response; dendritic cells; functional foods; polysaccharides; pullulanase
Mesh:
Substances:
Year: 2012 PMID: 23109818 PMCID: PMC3472710 DOI: 10.3390/ijms130910722
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 6.208
Figure 1(A) The flower of Nymphaea rubra Roxb.; (B) Schematic of a longitudinal section through a quartered portion of the flower, (sep) sepals, (pet) petals, (s) stamen, (ca) carpellary appendage, (c) carpel; (C) The carpel of Nymphaea rubra Roxb.
Composition of the crude extracts and hydrolysate from Nymphaea rubra Roxb.
| Extract | Yield | Total sugar | Reducing sugar | Protein |
|---|---|---|---|---|
| Crude | 1.43 | 55.86 ± 0.80 | 2.64± 0.34 | 7.84 ± 0.63 |
| Hydrolyzed | 42.00 | 51.30 ± 0.98 | 2.45 ± 0.92 | 5.28 ± 0.28 |
Data in the same row with different superscripts are significantly different at p ≤ 0.05.
Figure 2Morphology of dendritic cells after various treatments. (A) Bone marrow hematopoietic cells-imdendritic cells (BMHC-imDC) were grown from rat bone marrow in completed RPMI media 1640 containing 20 ng/mL recombinant rat GM-CSF and 10 ng/mL IL-4; (B) BMHC-imDC treated with 50 μg/mL NR-PS on day seven (200×); (C) A photomicrogaph of rat bone marrow hematopoietic cells (BMHC) isolated from four to seeks week old SD rats after staining with Liu’s-stain (200×); (D) BMHC-imDCs were generated from BMHC by treatment with 20 ng/mL GM-CSF and 10 ng/mL IL-4 for seven days. Note the presence of the short dendritic processes (arrow) associated with the plasma membrane (Liu’s staining, 200×); (E) Lipopolysaccharide(1 μg/mL) was used to stimulate the maturation of BMHC-imDC into BMHC-mDC. Note the presence of the long dendritic processes (arrow) associated with the plasma membrane (Liu’s staining, 200×); (F) Bone marrow hematopoietic cell-derived immature dendritic cells (BMHC-imDCs) treated with 50 μg/mL NR-PS for 48hr (Liu’s stain, 200×).
Figure 3Analysis of the surface phenotypes of BMHC-imDC using fluorescence activated cell sorting (FACS) scan. On day nine, non-adherent cells were stained with (A) fluorescein isothiocyanate (FITC) conjugated isotype control; (B) conjugated anti-rat CD11c antibody.
Effects of various concentrations of NR-PS on the expression of cell surface antigens on BMHC-imDCs.
| Groups | Percentages of cells with a positive cell surface antigen reaction | |
|---|---|---|
|
| ||
| CD 80/86 | MHC II | |
| Control | 65.45 ± 0.97 | 34.87 ± 1.96 |
| LPS (μg/mL) | ||
| 1 | 85.76 ± 3.06 | 73.20 ± 6.16 |
| NR-PS (μg/mL) | ||
| 3.125 | 84.49 ± 10.86 | 45.06 ± 8.11 |
| 6.25 | 84.80 ± 7.94 | 44.88 ± 5.11 |
| 12.5 | 85.68 ± 18.66 | 49.18 ± 10.41 |
| 25 | 87.16 ± 8.49 | 52.01 ± 10.11 |
| 50 | 84.44 ± 6.35 | 49.27 ± 5.03 |
| 100 | 84.56 ± 7.62 | 50.27 ± 5.24 |
Cell surface antigen expression was analyzed by flow cytometry and data in the same column with different superscripts are significantly different with p ≤ 0.05;
Data are expressed as mean ± SD: n = 3.
Comparison of the mean fluorescence intensity of dendritic cells across various concentrations of NR-PS.
| Groups | Mean fluorescence intensity of dendritic cells | |
|---|---|---|
|
| ||
| CD 80/86 | MHC II | |
| Control | 24.60 ± 3.19 | 46.55 ± 4.97 |
| LPS (μg/mL) | ||
| 1 | 49.00 ± 9.18 | 57.62 ± 1.87 |
| NR-PS (μg/mL) | ||
| 3.125 | 47.23 ± 3.72 | 51.09 ± 4.73 |
| 6.25 | 42.73 ± 4.20 | 51.94 ± 2.89 |
| 12.5 | 45.69 ± 3.58 | 55.62 ± 8.21 |
| 25 | 48.48 ± 4.26 | 60.74 ± 10.06 |
| 50 | 38.03 ± 6.27 | 57.30 ± 4.76 |
| 100 | 43.70 ± 7.61 | 57.70 ± 2.68 |
Cell surface antigen expression was analyzed by flow cytometry and data in the same column with different superscripts are significantly different with p ≤ 0.05;
Data are expressed as mean ± SD: n = 3.
Effect of various concentrations of NR-PS on the pinocytosis activity of BMHC-imDC.
| Groups | Uptake of FITC-dextran |
|---|---|
|
| |
| Mean fluorescence intensity | |
| Control 37 °C | 261.67 ± 47.26 |
| LPS (μg/mL) | |
| 1 | 121.60 ± 31.05 |
| NR-PS (μg/mL) | |
| 3.125 | 227.87 ± 35.88 |
| 6.25 | 192.47 ± 52.47 |
| 12.5 | 176.50 ± 28.52 |
| 25 | 167.94 ± 60.59 |
| 50 | 199.41 ± 24.52 |
| 100 | 211.49 ± 33.65 |
Pinocytosis activity was measured by the uptake of FITC-dextran (40,000 dalton; Sigma) and analyzed by FACScan flow cytometry. The data in the same column with different superscripts are significantly different at p ≤ 0.05;
Data are expressed as mean ± SD: n = 3.
Effect of various concentrations of NR-PS on IL-12, IL-10 and IFN-γ production by BMHC-im DCs.
| Groups | Level of cytokine | ||
|---|---|---|---|
|
| |||
| IL-12 | IL-10 | IFN-γ | |
| Control | 102.09 ± 10.16 | 30.75 ± 3.35 | 11.76 ± 0.11 |
| NR-PS (μg/mL) | |||
| 3.125 | 158.59 ± 37.85 | 23.20 ± 8.47 | 15.40 ± 1.52 |
| 6.25 | 221.40 ± 11.90 | 22.48 ± 5.44 | 15.33 ± 2.62 |
| 12.5 | 220.65 ± 17.09 | 18.16 ± 4.17 | 15.96 ± 2.66 |
| 25 | 258.78 ± 25.26 | 15.37 ± 2.35 | 15.51 ± 1.66 |
| 50 | 254.62 ± 36.22 | 14.83 ± 3.80 | 15.01 ± 1.47 |
| 100 | 194.48 ± 27.61 | 21.22 ± 2.11 | 15.67 ± 1.24 |
IL-12, IL10 and IFN-γ levels in the supernatants by ELISA. Data in the same row with different superscripts are significantly different at p ≤ 0.05;
Data are expressed as mean ± SD: n = 3.